HELP Helus Pharma Inc.
$10.52▲ +1.54%
Healthcare
Other
Volume 1.52M
Avg Volume (10D) 1.62M
Key Metrics & Fundamentals
Market Cap
$768.59M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.76 - 15.15
% vs 50 MA
-12.60%
% vs 200 MA
37.16%
RSI-14
43.4
MACD Histogram
-0.0300
Beta (1Y vs SPY)
2.25
Free Cash Flow
-$37.39M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$49.03M
COGS
–
Operating Exp
$49.08M
Operating Income
-$49.08M
EBIT
-$49.08M
Pretax Income
-$47.82M
Net Income
-$47.82M
EPS (Diluted)
-0.91
Price & Volume History
Loading chart…
Recent News
Helus Pharma Announces Co-Founders’ Transition from Executive Leadership as Company Advances Toward Next Stage of Development
GlobeNewswire · Oct 27, 2026 8:00 AM ET
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · Oct 26, 2026 6:02 PM ET
Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026
GlobeNewswire · Oct 21, 2026 4:10 PM ET
Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances
MarketBeat · Oct 21, 2026 2:04 PM ET
Cybin Inc. (HELP) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · Oct 20, 2026 11:00 AM ET
Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors
GlobeNewswire · Oct 15, 2026 7:30 AM ET
Helus Pharma to Host Investor Presentation on October 21, 2026
GlobeNewswire · Oct 8, 2026 7:30 AM ET
Helus Pharma Announces Completion of Legal Name Change
GlobeNewswire · Oct 1, 2026 7:30 AM ET
Cybin (HELP) Stock May Be Trading At A Premium Despite Fresh Depression Trial Data
Simply Wall St. · Sep 24, 2026 9:14 PM ET
Cybin (HELP) Shares Moved, What Is Behind The Fresh Attention?
Simply Wall St. · Sep 24, 2026 10:16 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See HELP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.